Michael J. Garabedian is a Professor in the Departments of Microbiology and Urology at NYU Grossman School of Medicine. His research focuses on nuclear receptor signaling in disease contexts including prostate cancer, atherosclerosis, and stress-related disorders. He holds dual appointments and serves as Acting Vice Chair for Education in Microbiology. Education: PhD in Biochemistry from Brandeis University (advisor not specified), followed by a postdoctoral fellowship at University of California, San Francisco studying glucocorticoid receptor mechanisms. Joined NYU Langone in 1994 as an Assistant Professor, transitioning to full Professor and expanding into urology research. Research Interests: The lab employs cutting-edge approaches like CRISPR screens, single-cell RNA-seq, and spatial transcriptomics to study: Nuclear receptor regulation in macrophages and immune cells Novel prostate cancer therapies targeting androgen receptors LXRα signaling in metabolic/vascular diseases Glucocorticoid effects on neuronal function during stress Collaborates with Susan Logan's lab on peptoid-based drug development. Lab Structure: 4 main researchers including co-mentored MD/PhD students Sophie Ruff and Jeff Schneider. Maintains close ties with the Logan Lab through shared projects. Lab Location: Alexandria Center for Life Science - East Tower, Room 324. Active in training programs as Faculty Senate Representative.








